CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M –positive lung cancer after osimertinib

ConclusionsCAPP-seq analysis of ctDNA was able to identify potentially targetable genetic alterations in patients with osimertinib resistance.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research